| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |